IMC Chicago’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$822K Sell
75,300
-10,000
-12% -$110K ﹤0.01% 4122
2026
Q2
$783K Buy
85,300
+48,300
+131% +$539K ﹤0.01% 4138
2026
Q1
$401K Sell
37,000
-31,300
-46% -$268K ﹤0.01% 4270
2025
Q4
$417K Sell
68,300
-29,300
-30% -$175K ﹤0.01% 3593
2025
Q3
$506K Buy
97,600
+10,500
+12% +$60.4K ﹤0.01% 3169
2025
Q2
$517K Buy
87,100
+31,900
+58% +$192K ﹤0.01% 2844
2025
Q1
$454K Buy
55,200
+30,700
+125% +$258K ﹤0.01% 2726
2024
Q4
$202K Buy
+24,500
New +$197K ﹤0.01% 3101
2024
Q3
– Sell
-40,300
Closed -$418K – 2980
2024
Q2
$418K Buy
+40,300
New +$442K ﹤0.01% 2363

Other funds holding PTEN

IMC Chicago's PTEN Position: Q3 2026 in Review

IMC Chicago sold out of Patterson-UTI (PTEN) in Q3 2026, closing a stake of 18,657 shares — an estimated $205K sold.

IMC Chicago first reported a position in PTEN in Q1 2025 and held it in 4 quarters. The position peaked at $385K in Q3 2025. 437 funds tracked by Wall St. Rank hold PTEN as of Q3 2026.

  • IMC Chicago reported no remaining Patterson-UTI position as of Q3 2026 after selling out during the quarter.
  • IMC Chicago sold 18,657 Patterson-UTI shares in Q3 2026, an estimated $205K.
  • IMC Chicago first reported a position in Patterson-UTI in Q1 2025 and held it in 4 quarters.
  • IMC Chicago's Patterson-UTI position peaked at $385K in Q3 2025.
  • 437 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2026.

Based on IMC Chicago's 13F filing for Q3 2026, filed 5 Nov 2026.